Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012)
NCT00073177 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 819
Last updated 2016-10-25
Summary
The aim of the study is to compare the effects of oral roflumilast with placebo on lung function in patients with asthma.
Conditions
Interventions
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
AstraZeneca AstraZeneca · AstraZeneca
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-11-30
Countries
- United States
- Argentina
- Colombia
- Mexico
- Peru
More Related Trials
-
Roflumilast Plus Montelukast in Adults With Severe Asthma
NCT01765192 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma
NCT01365533 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamic/Pharmacokinetic Interactions Between Oral Roflumilast and Inhaled Formoterol
NCT00940329 ·Status: COMPLETED ·Phase: PHASE1
-
Phosphodiesterase 4 Inhibitor, Roflumilast, and the Effects of Inhibition in Severe Asthma
NCT04108377 ·Status: TERMINATED ·Phase: PHASE1
-
Study in Patients With Asthma
NCT00215410 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients
NCT01197794 ·Status: COMPLETED ·Phase: PHASE2
-
Post Marketing Surveillance of Roflumilast in Korea
NCT02068456 ·Status: COMPLETED
-
Study in Patients With Asthma
NCT00215371 ·Status: COMPLETED ·Phase: PHASE2
-
PF-04191834 Single Dose Bronchodilatory Study In Asthma.
NCT00723021 ·Status: COMPLETED ·Phase: PHASE2
-
Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)
NCT00092144 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate GSK2190915 in Subjects With Mild Asthma
NCT00812773 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma
NCT03971539 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Roflumilast in Asthma Management (TRIM)
NCT03532490 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents
NCT01159912 ·Status: COMPLETED ·Phase: PHASE3
-
OC000459 Dose Finding Study in Patients With Mild to Moderate Persistent Asthma
NCT00890877 ·Status: COMPLETED ·Phase: PHASE2
-
An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma
NCT02219048 ·Status: TERMINATED ·Phase: PHASE2
-
A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
NCT00517816 ·Status: COMPLETED ·Phase: PHASE1
-
Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma
NCT03012061 ·Status: COMPLETED ·Phase: PHASE2
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
NCT01225913 ·Status: RECRUITING ·Phase: PHASE4
-
Study in Patients With Asthma
NCT00215397 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
NCT01436071 ·Status: COMPLETED ·Phase: PHASE3
-
Study in Mild Asthmatic Patients
NCT00748306 ·Status: COMPLETED ·Phase: PHASE2
-
A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma
NCT02479412 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
NCT07219173 ·Status: RECRUITING ·Phase: PHASE2
-
A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent Asthma
NCT00859404 ·Status: UNKNOWN ·Phase: PHASE2